Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleonora Lai

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Frontiers in Oncology|May 27, 2021
Are All Anti-Angiogenic Drugs the Same in the Treatment of Second-Line Metastatic Colorectal Cancer? Expert Opinion on Clinical PracticeEleonora Lai, Stefano Cascinu, Mario Scartozzi
International Journal of Molecular Sciences|June 24, 2022
EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor MicroenvironmentClelia Madeddu, Clelia Donisi, Nicole Liscia, et al.
Cancers|July 29, 2025
Divergent Immune-Metabolic Profiles in Endometriosis and Ovarian Cancer: A Cross-Sectional AnalysisManuela Neri, Elisabetta Sanna, Paolo Albino Ferrari, et al.
Clinical Practice and Epidemiology in Mental Health : CP & EMH|April 21, 2022
The Difficult Task of Diagnosing Depression in Elderly People with Cancer: A Systematic ReviewElena Massa, Clelia Donisi, Nicole Liscia, et al.
Frontiers in Oncology|August 29, 2022
Nivolumab drug holiday in patients treated for metastatic renal cell carcinoma: A real-world, single-centre experienceDavide Bimbatti, Michele Dionese, Eleonora Lai, et al.
International Journal of Molecular Sciences|March 13, 2025
Association Between TP53 Mutations and Platinum Resistance in a Cohort of High-Grade Serous Ovarian Cancer Patients: Novel Implications for Personalized TherapeuticsClelia Madeddu, Eleonora Lai, Manuela Neri, et al.
World Journal of Clinical Oncology|January 9, 2023
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not?Andrea Pretta, Eleonora Lai, Clelia Donisi, et al.
Anticancer Research|September 30, 2024
Systemic Inflammation Indexes and Risk of Immune-related Adverse Events in Patients With Metastatic Urothelial Carcinoma Treated With ImmunotherapyMichele Dionese, Davide Bimbatti, Francesco Pierantoni, et al.
Therapeutic Advances in Medical Oncology|June 26, 2023
Oxaliplatin prior to PARP inhibitor in BRCA-mutated ovarian cancerMaria Ornella Nicoletto, Alessandra Baldoni, Francesco Cavallin, et al.
Animals : an Open Access Journal From MDPI|June 10, 2022
Investigating the Ovarian Microstructure in the Genera <i>Helicolenus</i> and <i>Scorpaena</i> (Teleostei, Sub-Order Scorpaenoidei) with Implications for Ovarian Dynamics and SpawningCristina Porcu, Eleonora Lai, Andrea Bellodi, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Frontiers in Oncology|May 27, 2021
Are All Anti-Angiogenic Drugs the Same in the Treatment of Second-Line Metastatic Colorectal Cancer? Expert Opinion on Clinical PracticeEleonora Lai, Stefano Cascinu, Mario Scartozzi
International Journal of Molecular Sciences|June 24, 2022
EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor MicroenvironmentClelia Madeddu, Clelia Donisi, Nicole Liscia, et al.
Cancers|July 29, 2025
Divergent Immune-Metabolic Profiles in Endometriosis and Ovarian Cancer: A Cross-Sectional AnalysisManuela Neri, Elisabetta Sanna, Paolo Albino Ferrari, et al.
Clinical Practice and Epidemiology in Mental Health : CP & EMH|April 21, 2022
The Difficult Task of Diagnosing Depression in Elderly People with Cancer: A Systematic ReviewElena Massa, Clelia Donisi, Nicole Liscia, et al.
Frontiers in Oncology|August 29, 2022
Nivolumab drug holiday in patients treated for metastatic renal cell carcinoma: A real-world, single-centre experienceDavide Bimbatti, Michele Dionese, Eleonora Lai, et al.
International Journal of Molecular Sciences|March 13, 2025
Association Between TP53 Mutations and Platinum Resistance in a Cohort of High-Grade Serous Ovarian Cancer Patients: Novel Implications for Personalized TherapeuticsClelia Madeddu, Eleonora Lai, Manuela Neri, et al.
World Journal of Clinical Oncology|January 9, 2023
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not?Andrea Pretta, Eleonora Lai, Clelia Donisi, et al.
Anticancer Research|September 30, 2024
Systemic Inflammation Indexes and Risk of Immune-related Adverse Events in Patients With Metastatic Urothelial Carcinoma Treated With ImmunotherapyMichele Dionese, Davide Bimbatti, Francesco Pierantoni, et al.
Therapeutic Advances in Medical Oncology|June 26, 2023
Oxaliplatin prior to PARP inhibitor in BRCA-mutated ovarian cancerMaria Ornella Nicoletto, Alessandra Baldoni, Francesco Cavallin, et al.
Animals : an Open Access Journal From MDPI|June 10, 2022
Investigating the Ovarian Microstructure in the Genera <i>Helicolenus</i> and <i>Scorpaena</i> (Teleostei, Sub-Order Scorpaenoidei) with Implications for Ovarian Dynamics and SpawningCristina Porcu, Eleonora Lai, Andrea Bellodi, et al.
Pageof 8